Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer

References

• BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018.
   PubMed Web of Science ®Google Scholar
• ArnoldM, SierraMS, LaversanneM, SoerjomataramI, JemalA, BrayF. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-31091226818619
   PubMed Web of Science ®Google Scholar
• BenarbaB, PandiellaA. Colorectal cancer and medicinal plants: principle findings from recent studies. Biomed Pharmacother. 2018;107:408–423. doi:10.1016/j.biopha.2018.08.00630099345
   PubMed Web of Science ®Google Scholar
• McQuadeRM, StojanovskaV, BornsteinJC, NurgaliK. Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem. 2017;24(15):1537–1557. doi:10.2174/092986732466617011115243628079003
   PubMed Web of Science ®Google Scholar
• HuangS, PengW, MaoD, et al. Kangai injection, a traditional Chinese medicine, improves efficacy and reduces toxicity of chemotherapy in advanced colorectal cancer patients: a systematic review and meta-analysis. Evid Based Compl Alter Med. 2019;2019:8423037.
   PubMed Web of Science ®Google Scholar
• KongF, ZouH, LiuX, et al. miR-7112-3p targets PERK to regulate the endoplasmic reticulum stress pathway and apoptosis induced by photodynamic therapy in colorectal cancer CX-1 cells. Photodiagnosis Photodyn Ther. 2020;29:101663.31945549
   PubMed Web of Science ®Google Scholar
• XiangY, GuoZ, ZhuP, ChenJ, HuangY. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–1975. doi:10.1002/cam4.210830945475
   PubMed Web of Science ®Google Scholar
• MaoD, FengL, HuangS, ZhangS, PengW, ZhangS. Meta-analysis of xihuang pill efficacy when combined with chemotherapy for treatment of breast cancer. Evid Based Compl Alter Med. 2019;2019:3502460.
   PubMed Web of Science ®Google Scholar
• WangQ, JiaoL, WangS, et al. Maintenance chemotherapy with Chinese herb medicine formulas vs. with placebo in patients with advanced non-small cell lung cancer after first-line chemotherapy: a multicenter, randomized, double-blind trial. Front Pharmacol. 2018;9:1233.30459612
   PubMed Web of Science ®Google Scholar
• TangYC, ZhangY, ZhouJ, et al. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. Int J Oncol. 2018;52(1):127–138. doi:10.3892/ijo.2017.418329115601
   PubMed Web of Science ®Google Scholar
• ZhangQ, ChenX, LuoY, RenH, QiaoT. Fuzi enhances anti-tumor efficacy of radiotherapy on lung cancer. J Cancer. 2017;8(19):3945–3951. doi:10.7150/jca.2216229187869
   PubMed Web of Science ®Google Scholar
• LiuX, TianS, LiuM, JianL, ZhaoL. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NFkappaB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling. Int J Mol Med. 2016;38(4):1250–1256. doi:10.3892/ijmm.2016.270027499272
   PubMed Web of Science ®Google Scholar
• WangJ, ZhangT, ZhuL, MaC, WangS. Anti-ulcerogenic effect of Zuojin Pill against ethanol-induced acute gastric lesion in animal models. J Ethnopharmacol. 2015;173:459–467. doi:10.1016/j.jep.2015.04.01725959443
   PubMed Web of Science ®Google Scholar
• XuL, QiY, LvL, et al. In vitro anti-proliferative effects of Zuojinwan on eight kinds of human cancer cell lines. Cytotechnology. 2014;66(1):37–50. doi:10.1007/s10616-013-9534-x23397442
   PubMed Web of Science ®Google Scholar
• SunMY, SunJ, TaoJ, YuanYX, NiZH, TangQF. Zuo Jin Wan reverses DDP resistance in gastric cancer through ROCK/PTEN/PI3K signaling pathway. Evid Based Compl Alter Med. 2018;2018:4278568.
   PubMed Web of Science ®Google Scholar
• SuiH, PanSF, FengY, et al. Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-kappaB pathway. BMC Complement Altern Med. 2014;14:279.25085593
   PubMed Web of Science ®Google Scholar
• YanR, WangY, ShenW, LiuY, DiX. Comparative pharmacokinetics of dehydroevodiamine and coptisine in rat plasma after oral administration of single herbs and Zuojinwan prescription. Fitoterapia. 2011;82(8):1152–1159. doi:10.1016/j.fitote.2011.07.01221816210
   PubMed Web of Science ®Google Scholar
• ChouST, HsiangCY, LoHY, et al. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 2017;17(1):121. doi:10.1186/s12906-017-1586-628219365
   PubMed Web of Science ®Google Scholar
• DuJ, SunY, WangXF, LuYY, ZhouQM, SuSB. Establishment of an experimental breast cancer ZHENG model and curative effect evaluation of zuo-Jin Wan. Evid Based Compl Alter Med. 2013;2013:324732.
   PubMed Web of Science ®Google Scholar
• PanJ, XuY, SongH, ZhouX, YaoZ, JiG. Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/beta-catenin signaling in colorectal cancer cells. BMC Complement Altern Med. 2017;17(1):506. doi:10.1186/s12906-017-2006-729183322
   PubMed Web of Science ®Google Scholar
• SunM-Y, Wang-D-D, SunJ, et al. The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1. Chin J Nat Med. 2019;17(3):198–208. doi:10.1016/S1875-5364(19)30022-630910056
   PubMed Web of Science ®Google Scholar
• SuiH, LiuX, JinBH, et al. Zuo Jin Wan, a traditional Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo. Evid Based Compl Alter Med. 2013;2013:957078.
   PubMed Web of Science ®Google Scholar
• ZuoH, ZhangQ, SuS, ChenQ, YangF, HuY. A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: an example of Yu Ping Feng decoction. Sci Rep. 2018;8(1):11418. doi:10.1038/s41598-018-29764-130061691
   PubMed Web of Science ®Google Scholar
• ZengL, YangK. Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach. J Ethnopharmacol. 2017;199::68–85. doi:10.1016/j.jep.2017.01.045
   PubMed Web of Science ®Google Scholar
• JingC, SunZ, XieX, et al. Network pharmacology-based identification of the key mechanism of Qinghuo Rougan Formula acting on uveitis. Biomed Pharmacother. 2019;120:109381.31542616
   PubMed Web of Science ®Google Scholar
• XieG, PengW, LiP, et al. A network pharmacology analysis to explore the effect of astragali radix-radix angelica sinensis on traumatic brain injury. Biomed Res Int. 2018;2018:3951783.30596090
   PubMed Web of Science ®Google Scholar
• KimSK, LeeS, LeeMK, LeeS. A systems pharmacology approach to investigate the mechanism of Oryeong-san formula for the treatment of hypertension. J Ethnopharmacol. 2019;244:112129.31376514
   PubMed Web of Science ®Google Scholar
• RuJ, LiP, WangJ, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.24735618
   PubMed Web of Science ®Google Scholar
• MaierJK, LabuteP. Assessment of fully automated antibody homology modeling protocols in molecular operating environment. Proteins. 2014;82(8):1599–1610. doi:10.1002/prot.2457624715627
   PubMed Web of Science ®Google Scholar
• SadhukhanP, KunduM, ChatterjeeS, et al. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. Mater Sci Eng C Mater Biol Appl. 2019;100::129–140. doi:10.1016/j.msec.2019.02.096
   PubMed Web of Science ®Google Scholar
• RuanH, ZhanYY, HouJ, et al. Berberine binds RXRalpha to suppress beta-catenin signaling in colon cancer cells. Oncogene. 2017;36(50):6906–6918. doi:10.1038/onc.2017.29628846104
   PubMed Web of Science ®Google Scholar
• PanY, ShaoD, ZhaoY, et al. Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK- HIF-1alpha. Int J Biol Sci. 2017;13(6):794–803. doi:10.7150/ijbs.1896928656004
   PubMed Web of Science ®Google Scholar
• ZhengX, ZhangF, ShaoD, et al. Gram-scale production of carrier-free fluorescent berberine microrods for selective liver cancer therapy. BioFactors (Oxford, England). 2018;44(5):496–502. doi:10.1002/biof.1450
   PubMed Web of Science ®Google Scholar
• GuoXX, LiXP, ZhouP, et al. Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. 2018;19(11).
   Web of Science ®Google Scholar
• SuT, YangX, DengJH, et al. Evodiamine, a novel NOTCH3 methylation stimulator, significantly suppresses lung carcinogenesis in vitro and in vivo. Front Pharmacol. 2018;9:434.29765324
   PubMed Web of Science ®Google Scholar
• MassiA, BortoliniO, RagnoD, et al. Research progress in the modification of quercetin leading to anticancer agents. Molecules (Basel, Switzerland). 2017;22(8).
   PubMed Web of Science ®Google Scholar
• ZhangZ, LiB, XuP, YangB. Integrated whole transcriptome profiling and bioinformatics analysis for revealing regulatory pathways associated with quercetin-induced apoptosis in HCT-116 cells. Front Pharmacol. 2019;10:798.31379573
   PubMed Web of Science ®Google Scholar
• JiY, LiL, MaYX, et al. Quercetin inhibits growth of hepatocellular carcinoma by apoptosis induction in part via autophagy stimulation in mice. J Nutr Biochem. 2019;69::108–119. doi:10.1016/j.jnutbio.2019.03.018
   PubMed Web of Science ®Google Scholar
• LiS, PeiY, WangW, LiuF, ZhengK, ZhangX. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1. Biomed Pharmacother. 2019;114:108839.30978523
   PubMed Web of Science ®Google Scholar
• ChengS, GaoN, ZhangZ, et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res. 2010;16(23):5679–5691. doi:10.1158/1078-0432.CCR-10-156521138867
   PubMed Web of Science ®Google Scholar
• MauryaAK, VinayakM. PI-103 and quercetin attenuate PI3K-AKT signaling pathway in T-cell lymphoma exposed to hydrogen peroxide. PLoS One. 2016;11(8):e0160686. doi:10.1371/journal.pone.016068627494022
   PubMed Web of Science ®Google Scholar
• ChuangCH, ChanST, ChenCH, YehSL. Quercetin enhances the antitumor activity of trichostatin A through up-regulation of p300 protein expression in p53 null cancer cells. Chem Biol Interact. 2019;306::54–61. doi:10.1016/j.cbi.2019.04.006
   PubMed Web of Science ®Google Scholar
• LuJ, WangZ, LiS, et al. Quercetin Inhibits the Migration and Invasion of HCCLM3 Cells by Suppressing the Expression of p-Akt1, Matrix Metalloproteinase (MMP) MMP-2, and MMP-9. Med Sci Monit. 2018;24::2583–2589. doi:10.12659/MSM.906172
   Web of Science ®Google Scholar
• RefoloMG, D’AlessandroR, MalerbaN, et al. Anti proliferative and pro apoptotic effects of flavonoid quercetin are mediated by CB1 receptor in human colon cancer cell lines. J Cell Physiol. 2015;230(12):2973–2980. doi:10.1002/jcp.2502625893829
   PubMed Web of Science ®Google Scholar
• KimHS, WannatungT, LeeS, et al. Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer. Apoptosis. 2012;17(9):938–949. doi:10.1007/s10495-012-0719-022684842
   PubMed Web of Science ®Google Scholar
• KimGT, LeeSH, KimYM. Quercetin regulates sestrin 2-AMPK-mTOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells. J Cancer Prev. 2013;18(3):264–270. doi:10.15430/JCP.2013.18.3.26425337554
   PubMedGoogle Scholar
• XavierCP, LimaCF, RohdeM, Pereira-WilsonC. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol. 2011;68(6):1449–1457. doi:10.1007/s00280-011-1641-921479885
   PubMed Web of Science ®Google Scholar
• AlwhaibiA, VermaA, AdilMS, SomanathPR. The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacol Res. 2019;145:104270. doi:10.1016/j.phrs.2019.10427031078742
   PubMed Web of Science ®Google Scholar
• XuH, LinF, WangZ, et al. CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett. 2018;412:69–80. doi:10.1016/j.canlet.2017.09.03028964785
   PubMed Web of Science ®Google Scholar
• XueS, ZhouY, ZhangJ, et al. Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibition of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Am J Transl Res. 2019;11(4):2580–2589.31105864
   PubMed Web of Science ®Google Scholar
• YangHL, ThiyagarajanV, ShenPC, et al. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. J Exp Clin Cancer Res. 2019;38(1):186. doi:10.1186/s13046-019-1196-x31068208
   PubMed Web of Science ®Google Scholar
• ElzaiatM, HermanL, LegoisB, LegerT, TodeschiniAL, VeitiaRA. High-throughput exploration of the network dependent on AKT1 in mouse ovarian granulosa cells. Mol Cell Proteomics. 2019;18(7):1307–1319. doi:10.1074/mcp.RA119.00146130992313
   PubMed Web of Science ®Google Scholar
• ZhangM, LiuLP, ChenY, et al. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax. Life Sci. 2013;92(1):55–62. doi:10.1016/j.lfs.2012.10.02323142241
   PubMed Web of Science ®Google Scholar
• LiuJS, HuoCY, CaoHH, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine. 2019;61:152843.31039533
   PubMed Web of Science ®Google Scholar
• HossanMS, ChanZY, CollinsHM, et al. Cardiac glycoside cerberin exerts anticancer activity through PI3K/AKT/mTOR signal transduction inhibition. Cancer Lett. 2019;453:57–73. doi:10.1016/j.canlet.2019.03.03430930233
   PubMed Web of Science ®Google Scholar